Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSUPAR: SC Glargine vs IV Regular Insulin in TPN
NCT02706119Phase 4Completed
- Sponsor
- Andalusian Progress and Health Public Foundation
- Start
- Jul 2016
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Andalusian Progress and Health Public Foundation. Started Jul 2016; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02706119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02706119.